Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Invesco S&P 500 Low Volatility ETF
QTREX Quantum Ltd. - Ordinary Shares
Zurn Elkay Water Solutions Corporation Common Stock
Edit Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zymeworks Inc. - Common Stock
(NQ:
ZYME
)
30.13
UNCHANGED
Delayed Quote
Updated: 4:00 PM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Zymeworks Inc. - Common Stock
< Previous
1
2
3
Next >
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
October 24, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
October 23, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
October 19, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
October 15, 2026
Zymeworks to Report Third Quarter 2026 Financial Results on November 9, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition
September 28, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Completes Acquisition of Theravance Biopharma
September 23, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
August 25, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
August 11, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 06, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
July 16, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
June 14, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
May 14, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
May 13, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 07, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
April 21, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
April 16, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
April 09, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
April 01, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
March 30, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
March 24, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
March 18, 2026
Four presentations deliver new insights into zanidatamab, including its differentiated HER2 biology
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
March 17, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 02, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
March 02, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 02, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026
February 12, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
January 27, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
January 12, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Outlines Strategic Priorities and Outlook for 2026
January 11, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
